Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes-Reference-Cited by-同舟云学术

Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes

Published:2017-05 Issue:3 Volume:486 Page:858-863
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Haga Yuki,Kanda Tatsuo,Nakamoto Shingo,Nakamura Masato,Sasaki Reina,Wu Shuang,Yokosuka Osamu

Funder

Japan Agency for Medical Research and Development

Chugai Pharmaceutical

MSD

Abbvie

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference37 articles.

1. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity;Ott;Vaccine,2012

2. Effectiveness of hepatitis B treatment in clinical practice;Scaglione;Gastroenterology,2012

3. Hepatitis B virus RNA transcripts and DNA in chronic liver disease;Yokosuka;N. Engl. J. Med.,1986

4. Molecular biology of hepatitis B virus infection;Seeger;Virology,2015

5. Innate antiviral immune responses to hepatitis B virus;Ait-Goughoulte;Viruses,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells;Biochemical and Biophysical Research Communications;2024-11

2. Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review;World Journal of Hepatology;2023-12-27

3. Ubiquitin E3 ligase β‐TrCP negatively regulates surface protein of hepatitis B virus;Journal of Medical Virology;2023-03

4. TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome;Viral Immunology;2022-02-01

5. Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment;International Journal of Molecular Sciences;2022-01-29